Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share.
-
Shares outstanding
-
9,041,375
-
Total 13F shares
-
2,334,607
-
Share change
-
+317,563
-
Total reported value
-
$15,770,361
-
Price per share
-
$6.75
-
Number of holders
-
20
-
Value change
-
+$2,155,649
-
Number of buys
-
8
-
Number of sells
-
7
Institutional Holders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR) as of Q4 2024
As of 31 Dec 2024,
Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,334,607 shares.
The largest 10 holders included
Kynam Capital Management, LP, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, CRCM LP, FIL Ltd, MILLENNIUM MANAGEMENT LLC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Group, Inc., RENAISSANCE TECHNOLOGIES LLC, BANK OF AMERICA CORP /DE/, and HSG Holding Ltd.
This page lists
21
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.